ArticleFrontiers in nutrition2025
Multi-oil fat emulsion improves postoperative nutritional status and reduces complications in patients with hilar cholangiocarcinoma.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Immunomodulatory Effects of Clinically Used Fat Emulsion to Promote Angiogenesis and Osteogenesis for Bone Repair.Materials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hilar cholangiocarcinoma (HCCA) is a common and complex biliary tract tumor often accompanied by malnutrition and a high risk of postoperative complications. Effective nutritional support is critical for improving prognosis. This study aimed to investigate the effects of multi-oil fat emulsion on postoperative nutritional status, liver function, inflammatory response, and complication rates in patients with HCCA. Methods: A total of 88 patients with HCCA who underwent radical resection at our hospital between January 2022 and February 2024 were enrolled and randomly divided into two groups. The control group received 20% medium/long-chain fat milk injection, while the observation group received multi-oil fat milk injection, both combined with amino acid glucose solution for five consecutive days. Nutritional indices [albumin (ALB), hemoglobin (Hb), total protein (TP)], liver function indices [alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL)], inflammatory markers [C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6)], and postoperative complications were assessed. Results: After intervention, both groups showed improved nutritional and liver function indices and reduced inflammatory markers compared with baseline (all P<0.01). The observation group demonstrated significantly higher ALB, Hb, and TP levels and lower ALT, AST, TBIL, CRP, TNF-α, and IL-6 levels than the control group (all Discussion: Multi-oil fat emulsion provided superior benefits over conventional fat emulsion in enhancing postoperative nutritional status, improving liver function, and reducing systemic inflammation and complications in HCCA patients. These findings suggest that multi-oil fat emulsion may be a preferable option for postoperative parenteral nutrition in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.